New concepts in the management of infants and children with meningitis.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D002443:Ceftriaxone; D002513:Cephamycins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D008581:Meningitis / Q000188:drug therapy* / Q000209:etiology; D008583:Meningitis, Haemophilus / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D009070:Moxalactam; D013290:Streptococcal Infections / Q000188:drug therapy*; D013292:Streptococcus agalactiae
D000900:Anti-Bacterial Agents; D002513:Cephamycins; D005839:Gentamicins; D002701:Chloramphenicol; D002443:Ceftriaxone; D000667:Ampicillin; D002439:Cefotaxime; D009070:Moxalactam